3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Breast Neoplasms
44
Neoplasms
43
Lung Neoplasms
28
Colorectal Neoplasms
21
Carcinoma, Non-Small-Cell Lung
20
Prostatic Neoplasms
15
Ovarian Neoplasms
15
Pancreatic Neoplasms
13
Melanoma
11
Uterine Cervical Neoplasms
10
Neoplastic Cells, Circulating
9
Neoplasm Metastasis
9
Sarcoma
8
Multiple Myeloma
8
Head and Neck Neoplasms
8
Glioma
8
Glioblastoma
8
Hematologic Neoplasms
7
Colonic Neoplasms
7
Carcinoma, Hepatocellular
7
Lymphoma
6
Leukemia, Myeloid, Acute
6
Endometrial Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Gastrointestinal Neoplasms
5
Disease
5
Brain Neoplasms
5
Urinary Bladder Neoplasms
4
Rectal Neoplasms
4
Peritoneal Neoplasms
4
Interventions
Peripheral Blood Stem Cell Transplantation
10
Cyclosporine
10
fludarabine phosphate
9
Cyclophosphamide
9
Whole-Body Irradiation
8
Mycophenolic Acid
7
Melphalan
5
Filgrastim
5
Busulfan
5
Antilymphocyte Serum
5
Psychiatric Rehabilitation
4
Methylprednisolone
4
Etoposide
4
Radiotherapy
3
Methotrexate
3
Flow Cytometry
3
Cord Blood Stem Cell Transplantation
3
Aprepitant
3
Analgesia
3
plerixafor
2
Therapeutics
2
Ondansetron
2
Mechlorethamine
2
Granulocyte Colony-Stimulating Factor
2
Dexamethasone
2
Cytarabine
2
Carmustine
2
Calcium Dobesilate
2
thymoglobulin
1
sargramostim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Lymphoma, T-Cell, Cutaneous
×
Blood Specimen Collection
×
Clear all
NCT02539472
2016-04-18
DIAPREMYF
Assistance Publique - Hôpitaux de Paris
Phase NA
Unknown
620 enrolled